Atlas Trials

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Clinical trial NCT01918644 · COMPLETED

Trial details

NCT number
NCT01918644
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic Cancer
Start date
2014-04-08
Primary completion
2019-12-04
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.